Informational content only

Everything on this website is published by Matthew Brown ND, LLC, doing business as Ignite HRT, for general informational purposes only. That includes descriptions of hormone replacement therapy, testosterone therapy, medical weight loss, ED treatment, FAQs, pricing, and educational content. It is not medical advice, and it is not intended to diagnose, treat, cure, or prevent any disease or condition. Reading this website is not a substitute for a consultation and appropriate evaluation by a licensed clinician.

Clinical oversight and licensure

Care at Ignite HRT is provided by Matt Brown, ND, a naturopathic physician licensed in Oregon (license no. 4263) and Washington (license no. NATU.NT.61145661), practicing within the scope of naturopathic prescriptive authority defined by state law.

Consult your physician

Always seek the advice of your physician or another qualified health provider with any questions you have about a medical condition, medication, or treatment. That includes whether hormone therapy or weight loss medication is appropriate for you. Never disregard professional medical advice, or delay seeking it, because of something you read on this site. Decisions about treatment at Ignite HRT are made only after an individualized evaluation, which may include your history, symptoms, examination, medication review, and testing when clinically indicated. Do not start, stop, change, or share a prescription medicine based on website content; speak with the prescribing clinician.

Individual results vary

A review, patient story, or illustrative scenario is not evidence that another person will have the same response. Where we use composite or model-based illustrations, we identify them as such. Results vary and depend on many factors, including health status, the specific treatment, adverse effects, access, and adherence. We do not guarantee any particular result, timeline, amount of weight change, or symptom improvement.

Medication names, approval status, and eligibility

Mentioning a medication or active ingredient on this website does not mean that a specific product is available, appropriate for you, or FDA-approved for every use, dose, route, or patient. Eligibility and prescribing decisions are made individually. Read the product's current FDA-approved labeling and Medication Guide when applicable, and discuss benefits, contraindications, interactions, alternatives, and uncertainties with your prescriber.

FDA-approved, compounded, and off-label medications

FDA-approved drugs have been reviewed by the FDA for specified uses, formulations, and populations. Approval of one product does not extend to a compounded preparation, a different formulation, or every product containing the same active ingredient.
Compounded drugsare not FDA-approved. The FDA does not review a compounded preparation for safety, effectiveness, quality, or dosing accuracy before it is marketed. A compounded product containing semaglutide or tirzepatide is not a generic version of, and should not be represented as the same as, an FDA-approved product. A compounded medicine may be considered only when the prescribing clinician determines that a patient's clinical need cannot be met by an available FDA-approved drug and the prescription and dispensing comply with current federal and state requirements.
Off-label prescribing means prescribing an FDA-approved drug for a use, dose, route, or population not included in its approved labeling. Clinicians may prescribe off label when medically appropriate, but the FDA has not determined that the product is safe and effective for that particular use.

If a proposed treatment is compounded or off label, ask why it is being recommended, what FDA-approved alternatives exist, what evidence supports the use, which pharmacy will dispense it, and what risks and monitoring apply.

Hormone therapy terminology

“Bioidentical” describes a hormone that is chemically identical to a hormone the body produces. The term includes some FDA-approved products and some custom-compounded products. It does not by itself mean natural, safer, more effective, or free of side effects. Professional guidance generally prefers an FDA-approved hormone product when an appropriate option is available. Menopausal hormone therapy and testosterone therapy each have treatment-specific benefits, risks, contraindications, and monitoring requirements.

Weight-management medications

Obesity is a chronic condition. Some FDA-approved weight-management medications, including specific semaglutide and tirzepatide products, are approved for long-term use in eligible patients. Treatment may continue while it remains beneficial and tolerable, and weight regain is common after medication is stopped. Duration, continuation, or discontinuation should be decided with the prescriber rather than from a general website timeline.

Emergencies

This website and our patient messaging tools are not for urgent or emergency situations. If you are experiencing a medical emergency, such as chest pain, difficulty breathing, signs of a stroke, a severe allergic reaction, or thoughts of harming yourself, call 911 or go to the nearest emergency room immediately. For mental health crises, you can also call or text 988.

No endorsement of external content

Links to third-party websites, studies, or resources are provided for context. A link is not an endorsement of any third-party product or service. External material can change, so confirm current guidance and product labeling with the original publisher and your clinician.

Clinical information sources

Our website copy should be read alongside current guidance. Authoritative resources used for the July 2026 content update include:

Guidance and product labeling change. See our Privacy Policy for website data practices and our Health Information Privacy page for patient privacy practices.

Questions

If anything here is unclear, email info@ignitehrt.com or call 503-925-6605. Do not send sensitive medical information by ordinary email.

Medical Disclaimer